Capital Increase / Dilution2026-08-24

Amendment to Paid-in Capital Increase Details

KES

케스피온

079190

+0.05

Signal Score

50CNeutral
Score50 / 100

Historical Avg Return (5d)

+0.00%

Data Coverage

100%n=2797

Risk-adjusted indicator based on 2797 historical DART filings. For informational purposes only — not investment advice.

Financial Impact

NEUTRAL

Key Numbers

  • • Original Filing Date: August 18, 2026
  • • Amendment Date: August 24, 2026
  • • Previous Major Shareholder (10%+): Finger Co. 46.18%
  • • Amended Major Shareholder (10%+): Undisclosed
  • • Dilution Purpose: Listing maintenance and operating funds

AI Analysis Summary

KESPION Co., Ltd. filed an amendment to its Material Fact Report regarding a paid-in capital increase. The amendment primarily concerns the details of major investors in the third-party allocation. The previous disclosure listed Finger Co. with a 46.18% stake, which has now been removed as the final investor composition and ratios are pending confirmation. The capital increase aims to secure funds for listing maintenance and operations. The final investor details are expected to be disclosed later. Upon completion, 'Pureun Sobujang New Technology Investment Association No. 3' is expected to become the largest shareholder. The lack of specific financial figures for the capital increase makes a definitive financial impact assessment difficult, but the amendment itself is neutral.

How This Event Is Evaluated

Capital Raise Evaluation

Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.

AI is used to interpret disclosures and extract structured data.

Signal scores are generated using event-specific methodologies and quantitative models.

  • Potential dilution rate
  • Issuance or conversion price
  • Funding purpose
  • Shareholder value impact
Read our full scoring methodology →

This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.

AI-processed analysis. Based on: [기재정정]주요사항보고서(유상증자결정). Source: Financial Supervisory Service (금융감독원 전자공시시스템). Raw government data is not redistributed. Not investment advice.